Abstract:Background. Studies that looked at asthma airway remodeling pathogenesis and prevention have led to the discovery of the rat sarcoma viral oncogene (RAS) signaling pathway as a key mechanism that controls airway smooth muscle cell (ASMC) proliferation. Baicalin has great anti-inflammatory, proliferation-inhibited, and respiratory disease-relieving properties. However, the inhibitory effects and mechanisms of baicalin on ASMC-mediated airway remodeling in mice are still poorly understood. Methods. After establishing the asthmatic mice model by ovalbumin (OVA) and interfering with baicalin, airway remodeling characteristics such as airway resistance, mRNA, and protein expression levels of remodeling-related cytokines were measured by histopathological assessment, quantitative real-time polymerase chain reaction (qPCR), enzyme-linked immunosorbent assay (ELISA), and western blot. Further efforts on detailed mechanisms were used antibody arrays to compare the expression and activation of proteins involved in the RAS signaling pathway. In addition, validation experiments were performed in ASMC proliferation model and low-expression cells of the target gene by using shRNA. Results. In OVA-induced asthmatic mice model, baicalin significantly reduced the infiltration of inflammatory cells in lung tissue, attenuated airway resistance, and decreased mRNA and protein expression levels of remodeling-related cytokines such as interleukin-13 (IL-13), vascular endothelial growth factor (VEGF), transforming growth factor-beta 1 (TGF-β1), matrix metallopeptidase 9 (MMP9), and tissue inhibitor of metalloproteinase 1 (TIMP1). The results of antibody arrays involved in RAS signaling pathway revealed that OVA and baicalin administration altered the activation of protein kinase C alpha type (PKC-α), A-rapidly accelerated fibrosarcoma (A-RAF), mitogen-activated protein kinase 2 (MEK2), extracellular regulated MAP kinase (ERK), MAPK interacting serine/threonine kinase 1 (MNK1), and ETS transcription factor 1 (ELK1). The above results were further verified in the ASMC proliferation model. A-RAF silencing (shA-RAF) could promote ASMC proliferation and downregulate p-MEK2, p-ERK, p-MNK1, and p-ELK1 expression. Conclusion. The effects of baicalin against airway remodeling and ASMC proliferation might partially be achieved by suppressing the RAS signaling pathway. Baicalin may be a new therapeutic option for managing airway remodeling in asthma patients.

Roles of PKC-δ/mTOR/NF-κB Signaling Pathway in Airway Remodeling of Asthma Mouse Model

Effects of rapamycin on airway remodeling in asthmatic mice

Inhibition of P21-Activated Kinase 1 Attenuates the Cardinal Features of Asthma Through Suppressing the Lymph Node Homing of Dendritic Cells.

PI3K/AKT/mTOR and TLR4/MyD88/NF-κB Signaling Inhibitors Attenuate Pathological Mechanisms of Allergic Asthma

Phosphoinositide 3-Kinases Promotes Proliferation of Airway Smooth Muscle Cells in Asthmatic Rats

Effect of Pimecrolimus on Interleukin-33 Level in Mice with Atopic Dermatitis and Asthma

Effects of rapamycin on airway inflammation in mice with asthma during remission

Effects of NF-κB Inhibitor,Caffeic Acid Phenethyl Ester, on Early Airway Remodeling of Mice Induced with Acrolein

IL-33 Promotes Airway Remodeling in a Mouse Model of Asthma Via ERK1/2 Signaling Pathway

The inhibitory effect of resveratrol on airway remodeling in mice with chronic asthma

Baicalin Inhibits Airway Smooth Muscle Cells Proliferation Through the RAS Signaling Pathway in Murine Asthmatic Airway Remodeling Model

Inhibition of Protein Kinase C Delta Attenuates Allergic Airway Inflammation Through Suppression of PI3K/Akt/mTOR/HIF-1 Alpha/vegf Pathway.

Effect of MKK34 on airway β-catenin in a HDM-induced mouse asthma

Effects of Imperatorin on Airway Remodeling in Bronchial Asthma Through S1PR2/STAT3 Signaling Pathway.

Recombinant Pyrin Domain Protein Attenuates Airway Inflammation and Alleviates Epithelial-Mesenchymal Transition by Inhibiting Crosstalk Between TGFβ1 and Notch1 Signaling in Chronic Asthmatic Mice

A20 Domain Protein Inhibits OVA-induced Airway Remodeling by Modulating the NF-κB/TGF-β1/CTGF Signaling Pathway in Asthmatic Mice

A study on the effects of cysteinyl leukotriene receptor antagonist and corticosteroid on the expression levels of matrix metalloproteinase-2 in asthmatic mouse models

Effect of Valsartan on Asthma Mice's Airway Remodelling and CTGF Expression

Cytoskeleton Changes of Airway Smooth Muscle Cells in Juvenile Rats with Airway Remodeling in Asthma and the RhoA/ROCK Signaling Pathway Mechanism.

The miR-9-5p/KLF5/IL-1β Axis Regulates Airway Smooth Muscle Cell Proliferation and Apoptosis to Aggravate Airway Remodeling and Inflammation in Asthma

Rho-kinase Inhibitor Attenuates Airway Mucus Hypersecretion and Inflammation Partly by Downregulation of IL-13 and the JNK1/2-AP1 Signaling Pathway.